Company / EPS (Diluted)
Acadia Healthcare EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.24
FY2025
5-year range
-$7.59 / $2.98
FY2021-FY2025
Trend
-108.1%
vs FY2024
Sector context
#104 of 159
Health Care
What the data says
At $-0.24, Acadia Healthcare's eps (diluted) ranks #104 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $-7.59 in FY2022 to $2.98 in FY2024.
Based on SEC 10-K filings.
-0.24 in FY2025.
Declined from $2.10 to $-0.24 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#104 of 159 in Health CareTop 65% of 159This company -$0.24 Sector average $1.67
▼
-114.4% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 108.1% year-over-year.
- Ranks #104 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.24 | -108.1% |
| FY2024 | $2.98 | +41.9% |
| FY2023 | $2.10 | +127.7% |
| FY2022 | -$7.59 | -712.1% |
| FY2021 | $1.24 | +161.7% |
| FY2020 | -$2.01 | -187.4% |
| FY2019 | $2.30 | +3185.7% |
| FY2018 | $0.07 | -97.0% |
| FY2017 | $2.30 | +3185.7% |
| FY2016 | $0.07 | -95.7% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026